Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 May 27

PMID 37243244

Authors

Yexiao Cheng

Chengyang Ji

Hang-Yu Zhou

Heng Zheng

Aiping Wu

Affiliations

Soon will be listed here.

Abstract

The SARS-CoV-2 genomic data continue to grow, providing valuable information for researchers and public health officials. Genomic analysis of these data sheds light on the transmission and evolution of the virus. To aid in SARS-CoV-2 genomic analysis, many web resources have been developed to store, collate, analyze, and visualize the genomic data. This review summarizes web resources used for the SARS-CoV-2 genomic epidemiology, covering data management and sharing, genomic annotation, analysis, and variant tracking. The challenges and further expectations for these web resources are also discussed. Finally, we highlight the importance and need for continued development and improvement of related web resources to effectively track the spread and understand the evolution of the virus.

Citing Articles

Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020-2023.

Feng Y, Chen S, Wang A, Zhao Z, Chen C Front Public Health. 2024; 12:1491623.

PMID: 39635220 PMC: 11614776. DOI: 10.3389/fpubh.2024.1491623.

SARS-CoV-2 Genomic Epidemiology Dashboards: A Review of Functionality and Technological Frameworks for the Public Health Response.

Sitharam N, Tegally H, Silva D, Baxter C, de Oliveira T, Xavier J Genes (Basel). 2024; 15(7).

PMID: 39062655 PMC: 11275337. DOI: 10.3390/genes15070876.

Virus sequencing performance during the SARS-CoV-2 pandemic: a retrospective analysis of data from multiple rounds of external quality assessment in Austria.

Camp J, Puchhammer-Stockl E, Aberle S, Buchta C Front Mol Biosci. 2024; 11:1327699.

PMID: 38375507 PMC: 10875003. DOI: 10.3389/fmolb.2024.1327699.

An ARMS-Multiplex PCR Targeting SARS-CoV-2 Omicron Sub-Variants.

Bozidis P, Petridi E, Gartzonika K Pathogens. 2023; 12(8).

PMID: 37623977 PMC: 10459702. DOI: 10.3390/pathogens12081017.

References

Chen J, Gao K, Wang R, Wei G . Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies. Chem Sci. 2021; 12(20):6929-6948. PMC: 8153213. DOI: 10.1039/d1sc01203g. View

. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020; 5(4):536-544. PMC: 7095448. DOI: 10.1038/s41564-020-0695-z. View

Hufsky F, Lamkiewicz K, Almeida A, Aouacheria A, Arighi C, Bateman A . Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research. Brief Bioinform. 2020; 22(2):642-663. PMC: 7665365. DOI: 10.1093/bib/bbaa232. View

Tsueng G, Mullen J, Alkuzweny M, Cano M, Rush B, Haag E . Outbreak.info Research Library: a standardized, searchable platform to discover and explore COVID-19 resources. Nat Methods. 2023; 20(4):536-540. PMC: 10393269. DOI: 10.1038/s41592-023-01770-w. View

Tay J, Porter A, Wirth W, Duchene S . The Emergence of SARS-CoV-2 Variants of Concern Is Driven by Acceleration of the Substitution Rate. Mol Biol Evol. 2022; 39(2). PMC: 8807201. DOI: 10.1093/molbev/msac013. View

. An integrated national scale SARS-CoV-2 genomic surveillance network. Lancet Microbe. 2020; 1(3):e99-e100. PMC: 7266609. DOI: 10.1016/S2666-5247(20)30054-9. View

Mallapaty S . Where did Omicron come from? Three key theories. Nature. 2022; 602(7895):26-28. DOI: 10.1038/d41586-022-00215-2. View

van Dorp L, Acman M, Richard D, Shaw L, Ford C, Ormond L . Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020; 83:104351. PMC: 7199730. DOI: 10.1016/j.meegid.2020.104351. View

Phan T . Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020; 81:104260. PMC: 7106203. DOI: 10.1016/j.meegid.2020.104260. View

10.

Alam I, Radovanovic A, Incitti R, Kamau A, Alarawi M, Azhar E . CovMT: an interactive SARS-CoV-2 mutation tracker, with a focus on critical variants. Lancet Infect Dis. 2021; 21(5):602. PMC: 7906688. DOI: 10.1016/S1473-3099(21)00078-5. View

11.

Cao Y, Jian F, Yu Y, Song W, Yisimayi A, Wang J . Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2022; 614(7948):521-529. PMC: 9931576. DOI: 10.1038/s41586-022-05644-7. View

12.

Wilkinson S, Richter A, Casey A, Osman H, Mirza J, Stockton J . Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol. 2022; 8(2):veac050. PMC: 9384748. DOI: 10.1093/ve/veac050. View

13.

Shi R, Shan C, Duan X, Chen Z, Liu P, Song J . A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020; 584(7819):120-124. DOI: 10.1038/s41586-020-2381-y. View

14.

Valesano A, Rumfelt K, Dimcheff D, Blair C, Fitzsimmons W, Petrie J . Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. PLoS Pathog. 2021; 17(4):e1009499. PMC: 8055005. DOI: 10.1371/journal.ppat.1009499. View

15.

Kistler K, Huddleston J, Bedford T . Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2. Cell Host Microbe. 2022; 30(4):545-555.e4. PMC: 8938189. DOI: 10.1016/j.chom.2022.03.018. View

16.

Rochman N, Wolf Y, Faure G, Mutz P, Zhang F, Koonin E . Ongoing global and regional adaptive evolution of SARS-CoV-2. Proc Natl Acad Sci U S A. 2021; 118(29). PMC: 8307621. DOI: 10.1073/pnas.2104241118. View

17.

Starr T, Greaney A, Hannon W, Loes A, Hauser K, Dillen J . Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science. 2022; 377(6604):420-424. PMC: 9273037. DOI: 10.1126/science.abo7896. View

18.

Sanderson T . Taxonium, a web-based tool for exploring large phylogenetic trees. Elife. 2022; 11. PMC: 9704803. DOI: 10.7554/eLife.82392. View

19.

Braun K, Moreno G, Wagner C, Accola M, Rehrauer W, Baker D . Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks. PLoS Pathog. 2021; 17(8):e1009849. PMC: 8412271. DOI: 10.1371/journal.ppat.1009849. View

20.

Yang H, Rao Z . Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021; 19(11):685-700. PMC: 8447893. DOI: 10.1038/s41579-021-00630-8. View